Search

Your search keyword '"Frankenberger, Marion"' showing total 274 results

Search Constraints

Start Over You searched for: Author "Frankenberger, Marion" Remove constraint Author: "Frankenberger, Marion"
274 results on '"Frankenberger, Marion"'

Search Results

1. FK506-Binding Protein 11 Is a Novel Plasma Cell-Specific Antibody Folding Catalyst with Increased Expression in Idiopathic Pulmonary Fibrosis

4. Proteomics reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients

6. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

7. Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through ‘reverse phenotyping’

10. Late Breaking Abstract - Thromboinflammation a common signature across age in chronic lung disease

11. Myeloid-dependent immunosuppressive features drive IPF progression

13. Antiviral CD8+T-cell immune responses are impaired by cigarette smoke and in COPD

14. Corrigendum: Monocyte signature as a predictor of chronic lung disease in the preterm infant

15. Monocyte signature as a predictor of chronic lung disease in the preterm infant

16. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry

19. Activation of immune cell proteasomes in peripheral blood of smokers and COPD patients: implications for therapy.

23. Proteome reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients

27. Activation of immune cell proteasomes in peripheral blood of smokers and COPD patients: implications for therapy

29. Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities

30. Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities

36. Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'

37. Idiopathic Pulmonary Fibrosis in Elderly Patients: Analysis of the INSIGHTS-IPF Observational Study

39. Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry

40. A proteomics workflow reveals predictive autoantigens in idiopathic pulmonary fibrosis

43. Single-cell RNA sequencing revealsin vivosignatures of SARS-CoV-2-reactive T cells through ‘reverse phenotyping’

45. FK506-binding protein 11, a novel plasma cell specific antibody folding catalyst, is increased in idiopathic pulmonary fibrosis

46. Short-Term Effects of Comprehensive Pulmonary Rehabilitation and its Maintenance in Patients with Idiopathic Pulmonary Fibrosis: A Randomized Controlled Trial

47. Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry

48. Distinct scavenger receptor expression and function in the human CD14+/CD16+ monocyte subset

49. Additional file 2: of The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry

50. Additional file 1: of The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry

Catalog

Books, media, physical & digital resources